| human | Q5 |
| P269 | IdRef ID | 243687346 |
| P496 | ORCID iD | 0000-0002-1121-4894 |
| P1053 | ResearcherID | C-7256-2008 |
| P214 | VIAF ID | 1817159234135303370868 |
| P735 | given name | Frank | Q220546 |
| Frank | Q220546 | ||
| P106 | occupation | researcher | Q1650915 |
| P5008 | on focus list of Wikimedia project | WikiProject COVID-19 | Q87748614 |
| P21 | sex or gender | male | Q6581097 |
| Q59334508 | 967. Inhibition of Host Neuraminidase Increases Susceptibility to Invasive Pulmonary Aspergillosis |
| Q40463693 | A Functional Genomics Approach to Understand Variation in Cytokine Production in Humans. |
| Q93042542 | A Genome-Wide Functional Genomics Approach Identifies Susceptibility Pathways to Fungal Bloodstream Infection in Humans |
| Q40128384 | A guiding map for inflammation |
| Q28540595 | A polysaccharide virulence factor from Aspergillus fumigatus elicits anti-inflammatory effects through induction of Interleukin-1 receptor antagonist |
| Q92689765 | A systems genomics approach identifies SIGLEC15 as a susceptibility factor in recurrent vulvovaginal candidiasis |
| Q40834677 | An anti-inflammatory property of Candida albicans β-glucan: Induction of high levels of interleukin-1 receptor antagonist via a Dectin-1/CR3 independent mechanism |
| Q97678142 | An exaggerated monocyte-derived cytokine response to Candida hyphae in patients with recurrent vulvovaginal candidiasis |
| Q38654393 | An integrative genomics approach identifies novel pathways that influence candidaemia susceptibility |
| Q104278080 | Anakinra treatment in critically ill COVID-19 patients: a prospective cohort study |
| Q43225292 | Anti-Aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity. |
| Q38295131 | Antifungal innate immunity: recognition and inflammatory networks |
| Q40838979 | Aspergillus Cell Wall Melanin Blocks LC3-Associated Phagocytosis to Promote Pathogenicity |
| Q41997165 | Aspergillus fumigatus morphology and dynamic host interactions |
| Q44947091 | Aspergillus fumigatus-induced IL-22 is not restricted to a specific Th cell subset and is dependent on complement receptor 3. |
| Q120345739 | Author Correction: Trained immunity, tolerance, priming and differentiation: distinct immunological processes |
| Q38645577 | Autoimmune Regulator Deficiency Results in a Decrease in STAT1 Levels in Human Monocytes |
| Q35377891 | Autophagy controls BCG-induced trained immunity and the response to intravesical BCG therapy for bladder cancer |
| Q41863342 | Autophagy modulates Borrelia burgdorferi-induced production of interleukin-1β (IL-1β) |
| Q38741955 | Basic Genetics and Immunology of Candida Infections |
| Q34393127 | Biology of IL-36 cytokines and their role in disease |
| Q97589284 | Blocking IL-1 to prevent respiratory failure in COVID-19 |
| Q37612411 | Borrelia species induce inflammasome activation and IL-17 production through a caspase-1-dependent mechanism |
| Q46680943 | Borrelia-induced cytokine production is mediated by spleen tyrosine kinase (Syk) but is Dectin-1 and Dectin-2 independent. |
| Q40765104 | Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis |
| Q46119741 | Bypassing pathogen-induced inflammasome activation for the regulation of interleukin-1beta production by the fungal pathogen Candida albicans |
| Q40588827 | CBLB ubiquitin ligase: a major regulator of antifungal immunity |
| Q95614531 | COVID-19 patients exhibit less pronounced immune suppression compared with bacterial septic shock patients |
| Q42972455 | Candida albicans dampens host defense by downregulating IL-17 production. |
| Q37967076 | Candida albicans morphogenesis and host defence: discriminating invasion from colonization. |
| Q120499615 | Caspase-1, but not ASC or NLRP3 inflammasome components, mediates IL-1beta activation and antifungal defense in disseminated candidiasis |
| Q112298597 | Comparative host transcriptome in response to pathogenic fungi identifies common and species-specific transcriptional antifungal host response pathways |
| Q35668803 | Compartmentalized Cytokine Responses in Hidradenitis Suppurativa |
| Q37442775 | Corticosteroids block autophagy protein recruitment in Aspergillus fumigatus phagosomes via targeting dectin-1/Syk kinase signaling |
| Q34057772 | Cytokine production assays reveal discriminatory immune defects in adults with recurrent infections and noninfectious inflammation |
| Q37865925 | Defects of pattern recognition: primary immunodeficiencies of the innate immune system |
| Q46905194 | Deficient Candida-specific T-helper 17 response during sepsis |
| Q42729335 | Deficient autophagy unravels the ROS paradox in chronic granulomatous disease |
| Q47556941 | Development of Endotoxin Tolerance Does Not Influence the Response to a Challenge with the Mucosal Live-Attenuated Influenza Vaccine in Humans In Vivo |
| Q47296348 | Differential Kinetics of Aspergillus nidulans and Aspergillus fumigatus Phagocytosis. |
| Q37119939 | Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages |
| Q85092283 | Diversity: A Hallmark of Monocyte Society |
| Q112689993 | Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial |
| Q98900263 | Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial |
| Q28384291 | Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1β production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis |
| Q56942360 | Erratum: IL-1 family nomenclature |
| Q28728570 | Exposure to Candida albicans polarizes a T-cell driven arthritis model towards Th17 responses, resulting in a more destructive arthritis |
| Q94923225 | FAVORABLE ANAKINRA RESPONSES IN SEVERE COVID-19 PATIENTS WITH SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
| Q40131074 | Flucloxacillin Results in Suboptimal Plasma Voriconazole Concentrations. |
| Q38976165 | Gain-of-function STAT1 mutations impair STAT3 activity in patients with chronic mucocutaneous candidiasis (CMC). |
| Q34341908 | Genetic susceptibility to Candida infections |
| Q119570977 | Genome-Wide Association Study Reveals CLEC7A and PROM1 as Potential Regulators of Paracoccidioides brasiliensis-Induction of Cytokine Production in Peripheral Blood Mononuclear Cells |
| Q39170824 | Glutaminolysis and Fumarate Accumulation Integrate Immunometabolic and Epigenetic Programs in Trained Immunity |
| Q34523567 | Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype |
| Q37207462 | Host-microbe interactions: innate pattern recognition of fungal pathogens |
| Q40850228 | Human Neutrophils Use Different Mechanisms To Kill Aspergillus fumigatus Conidia and Hyphae: Evidence from Phagocyte Defects. |
| Q101136069 | Human recombinant interleukin-38 suppresses inflammation in mouse models of local and systemic disease |
| Q34144622 | IL-1 family nomenclature |
| Q36690556 | IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosis |
| Q37627905 | IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans |
| Q120499612 | IL-1-8 IL-1β and the development of Th17 responses |
| Q33535878 | IL-1beta processing in host defense: beyond the inflammasomes |
| Q28072571 | IL-1β/IL-6/CRP and IL-18/ferritin: Distinct Inflammatory Programs in Infections |
| Q28544789 | IL-37 inhibits inflammasome activation and disease severity in murine aspergillosis |
| Q35779110 | IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist |
| Q41660745 | IL1B and DEFB1 Polymorphisms Increase Susceptibility to Invasive Mold Infection After Solid-Organ Transplantation |
| Q103826980 | Immune defects in patients with pulmonary Mycobacterium abscessus disease without cystic fibrosis |
| Q38590007 | Immune defence against Candida fungal infections |
| Q37481373 | Immunochip SNP array identifies novel genetic variants conferring susceptibility to candidaemia. |
| Q40692540 | Immunologic defects in severe mucocutaneous HSV-2 infections: Response to IFN-γ therapy |
| Q40107600 | Immunotherapeutic approaches to treatment of fungal diseases. |
| Q38259013 | Immunotherapy: a potential adjunctive treatment for fungal infection |
| Q38803776 | In-host adaptation and acquired triazole resistance in Aspergillus fumigatus: a dilemma for clinical management |
| Q37844754 | Inflammasome activation and IL-1β and IL-18 processing during infection |
| Q35216914 | Inflammasome is a central player in the induction of obesity and insulin resistance |
| Q33872210 | Inflammasome-independent modulation of cytokine response by autophagy in human cells |
| Q38286016 | Inflammasome-independent regulation of IL-1-family cytokines |
| Q33782663 | Inflammasome-independent role of apoptosis-associated speck-like protein containing a CARD (ASC) in T cell priming is critical for collagen-induced arthritis |
| Q30400852 | Influenza-Associated Aspergillosis in Critically Ill Patients. |
| Q35567246 | Inhibition of caspase-1 activation in Gram-negative sepsis and experimental endotoxemia |
| Q35131761 | Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series |
| Q96291810 | Invasive Aspergillus Tracheobronchitis Emerging as Highly Lethal Complication of Severe Influenza |
| Q93253714 | Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome |
| Q38835840 | LC3-associated phagocytosis: a crucial mechanism for antifungal host defence against Aspergillus fumigatus |
| Q83105970 | Low interleukin-17A production in response to fungal pathogens in patients with chronic granulomatous disease |
| Q50065334 | Metabolic Induction of Trained Immunity through the Mevalonate Pathway. |
| Q104518207 | Mimicking Behcet's disease: GM-CSF gain of function mutation in a family suffering from a Behcet's disease-like disorder marked by extreme pathergy |
| Q28082840 | Modulation of inflammation by autophagy: Consequences for human disease |
| Q112637942 | Multi-Omics Integration Reveals Only Minor Long-Term Molecular and Functional Sequelae in Immune Cells of Individuals Recovered From COVID-19 |
| Q36907628 | Murine Borrelia arthritis is highly dependent on ASC and caspase-1, but independent of NLRP3. |
| Q43124577 | Mycobacterium tuberculosis induces IL-17A responses through TLR4 and dectin-1 and is critically dependent on endogenous IL-1. |
| Q43685729 | Neutrophil-mediated inhibition of proinflammatory cytokine responses |
| Q38121074 | New Insights in the Immunobiology of IL-1 Family Members |
| Q37763270 | Novel strategies for the prevention and treatment of Candida infections: the potential of immunotherapy |
| Q119571018 | Opposing Effects of Interleukin-36γ and Interleukin-38 on Trained Immunity |
| Q37780092 | Pathogenesis of invasive candidiasis |
| Q41054725 | Pathogenic NLRP3 Inflammasome Activity during Candida Infection Is Negatively Regulated by IL-22 via Activation of NLRC4 and IL-1Ra |
| Q38751066 | Personalized medicine in influenza: a bridge too far or the near future? |
| Q94569365 | Phagosomal removal of fungal melanin reprograms macrophage metabolism to promote antifungal immunity |
| Q97517273 | Primary immunodeficiencies in cytosolic pattern-recognition receptor pathways: Toward host-directed treatment strategies |
| Q38717292 | Progressive multifocal leukoencephalopathy in an immunocompetent patient |
| Q34851532 | Protective host defense against disseminated candidiasis is impaired in mice expressing human interleukin-37. |
| Q24624942 | Reactive oxygen species-independent activation of the IL-1beta inflammasome in cells from patients with chronic granulomatous disease |
| Q42687677 | Receptor recognition of and immune intracellular pathways for Veillonella parvula lipopolysaccharide |
| Q101126059 | Reduced concentrations of the B cell cytokine Interleukin 38 are associated with cardiovascular disease risk in overweight subjects |
| Q39742832 | Reducing hypoxia and inflammation during invasive pulmonary aspergillosis by targeting the Interleukin-1 receptor |
| Q96642114 | Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion |
| Q41996952 | Rewiring monocyte glucose metabolism via C-type lectin signaling protects against disseminated candidiasis |
| Q47127905 | Risks of Ruxolitinib in STAT1 Gain-of-Function-Associated Severe Fungal Disease |
| Q44211471 | Role of TLR1 and TLR6 in the host defense against disseminated candidiasis |
| Q35671653 | Role of interleukin-23 (IL-23) receptor signaling for IL-17 responses in human Lyme disease |
| Q34110879 | STAT1 hyperphosphorylation and defective IL12R/IL23R signaling underlie defective immunity in autosomal dominant chronic mucocutaneous candidiasis |
| Q34196284 | STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis |
| Q90030526 | STAT3 phosphorylation mediates the stimulatory effects of interferon alpha on B cell differentiation and activation in SLE |
| Q98663508 | Safety and COVID-19 Symptoms in Individuals Recently Vaccinated with BCG: a Retrospective Cohort Study |
| Q37815686 | Severe Candida spp. infections: new insights into natural immunity |
| Q33709446 | Skin microbiome imbalance in patients with STAT1/STAT3 defects impairs innate host defense responses |
| Q37803134 | T-cell Subsets and Antifungal Host Defenses |
| Q41301353 | TREML4 adds fuel to the TLR7 fire |
| Q30415829 | Th17 cytokine deficiency in patients with Aspergillus skull base osteomyelitis |
| Q37665895 | Th17 responses and host defense against microorganisms: an overview |
| Q119684385 | The BNT162b2 mRNA Vaccine Against SARS-CoV-2 Reprograms Both Adaptive and Innate Immune Responses |
| Q42830119 | The Candida Th17 response is dependent on mannan- and beta-glucan-induced prostaglandin E2. |
| Q24303676 | The IL-36 receptor pathway regulates Aspergillus fumigatus-induced Th1 and Th17 responses |
| Q37374119 | The RIG-I-like helicase receptor MDA5 (IFIH1) is involved in the host defense against Candida infections |
| Q36786137 | The Role of Dectin-2 for Host Defense Against Disseminated Candidiasis |
| Q84417973 | The classical CD14⁺⁺ CD16⁻ monocytes, but not the patrolling CD14⁺ CD16⁺ monocytes, promote Th17 responses to Candida albicans |
| Q42385375 | The dectin-1/inflammasome pathway is responsible for the induction of protective T-helper 17 responses that discriminate between yeasts and hyphae of Candida albicans |
| Q34558300 | The discriminative capacity of soluble Toll-like receptor (sTLR)2 and sTLR4 in inflammatory diseases. |
| Q46310614 | The effects of in vivo B-cell depleting therapy on ex-vivo cytokine production |
| Q41993160 | The effects of signal transducer and activator of transcription three mutations on human platelets. |
| Q30234689 | The immunopathology of sepsis and potential therapeutic targets |
| Q37612479 | The inflammasome drives protective Th1 and Th17 cellular responses in disseminated candidiasis. |
| Q38423391 | The interplay between inflammasome activation and antifungal host defense |
| Q46044007 | The macrophage mannose receptor induces IL-17 in response to Candida albicans. |
| Q35277785 | The potential impact of the pulmonary microbiome on immunopathogenesis of Aspergillus-related lung disease |
| Q38232426 | The role of interleukin-1 family members in the host defence against Aspergillus fumigatus |
| Q40047847 | Toll-like receptor 2 induced cytotoxic T-lymphocyte-associated protein 4 regulates Aspergillus-induced regulatory T-cells with pro-inflammatory characteristics |
| Q95295198 | Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection |
| Q104135153 | Trained immunity, tolerance, priming and differentiation: distinct immunological processes |
| Q38830589 | Treatment options for chronic mucocutaneous candidiasis |
| Q42209674 | Two independent killing mechanisms of Candida albicans by human neutrophils: evidence from innate immunity defects. |
| Q40588833 | Understanding human immune function using the resources from the Human Functional Genomics Project |
| Q45141589 | Uric acid priming in human monocytes is driven by the AKT-PRAS40 autophagy pathway |
| Q35914364 | When the Fight against Fungi Goes Wrong |
| Q34481477 | mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity. |
Search more.